Cargando…

Ferroptosis Mediation Patterns Reveal Novel Tool to Implicate Immunotherapy and Multi-Omics Characteristics in Bladder Cancer

Background: The regulatory role of ferroptosis in malignant tumours has been recently demonstrated. However, the potential roles of ferroptosis mediation patterns in bladder cancer remain elusive. Materials and Methods: The ferroptosis mediation patterns of 889 bladder cancer samples were comprehens...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jingchao, Zhang, Zhipeng, Zhang, Wei, Meng, Lingfeng, Wang, Jiawen, Lv, Zhengtong, Xia, Haoran, Wu, Meng, Zhang, Yaoguang, Wang, Jianye
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8821925/
https://www.ncbi.nlm.nih.gov/pubmed/35145965
http://dx.doi.org/10.3389/fcell.2022.791630
_version_ 1784646501802180608
author Liu, Jingchao
Zhang, Zhipeng
Zhang, Wei
Meng, Lingfeng
Wang, Jiawen
Lv, Zhengtong
Xia, Haoran
Wu, Meng
Zhang, Yaoguang
Wang, Jianye
author_facet Liu, Jingchao
Zhang, Zhipeng
Zhang, Wei
Meng, Lingfeng
Wang, Jiawen
Lv, Zhengtong
Xia, Haoran
Wu, Meng
Zhang, Yaoguang
Wang, Jianye
author_sort Liu, Jingchao
collection PubMed
description Background: The regulatory role of ferroptosis in malignant tumours has been recently demonstrated. However, the potential roles of ferroptosis mediation patterns in bladder cancer remain elusive. Materials and Methods: The ferroptosis mediation patterns of 889 bladder cancer samples were comprehensively evaluated based on ferroptosis-related genes. The underlying correlations between these mediation patterns and multi-omic characteristics of bladder cancer were systematically analysed. The ferroptosis mediation patterns of individual samples were quantified by ferropscore using the principal component analysis algorithm. The typical ferroptosis-related genes with prognostic roles were further randomly validated using immunohistochemical staining, real-time polymerase chain reaction and western blotting. Results: Three different ferroptosis mediation patterns were identified. The abundance of infiltration of 23 immune cells was different among the three mediation patterns. The quantification of ferroptosis mediation patterns in individual samples served as a promising tool for predicting patient survival outcomes; immune cell infiltration abundance; tumour mutation burden; oncogenic mutation status and tumour grade, stage and molecular subtypes. Low ferropscore combined with high tumour mutation burden was associated with the best survival prognosis. Expressions of PD-L1 (p < 0.001), PD-1 (p = 0.002) and CTLA-4 (p = 0.003) were all significantly upregulated in the high ferropscore group. Low ferropscores also predicted good immunotherapy response for anti-CTLA4 strategy. The mRNA and protein levels of FADS2, a typical ferroptosis-related gene used in the study, were higher in bladder cancer cell lines than in controlled SV-HUC-1 cells. In addition, immunohistochemical staining revealed significantly higher expression levels of FADS2 in human bladder cancer tumour tissues than in normal tissues. Conclusion: This study identified three distinct ferroptosis mediation patterns in bladder cancer. Quantification of ferroptosis mediation patterns in individual samples may help to improve the understanding of multiomic characteristics and guide future immunotherapy responses to bladder cancer.
format Online
Article
Text
id pubmed-8821925
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-88219252022-02-09 Ferroptosis Mediation Patterns Reveal Novel Tool to Implicate Immunotherapy and Multi-Omics Characteristics in Bladder Cancer Liu, Jingchao Zhang, Zhipeng Zhang, Wei Meng, Lingfeng Wang, Jiawen Lv, Zhengtong Xia, Haoran Wu, Meng Zhang, Yaoguang Wang, Jianye Front Cell Dev Biol Cell and Developmental Biology Background: The regulatory role of ferroptosis in malignant tumours has been recently demonstrated. However, the potential roles of ferroptosis mediation patterns in bladder cancer remain elusive. Materials and Methods: The ferroptosis mediation patterns of 889 bladder cancer samples were comprehensively evaluated based on ferroptosis-related genes. The underlying correlations between these mediation patterns and multi-omic characteristics of bladder cancer were systematically analysed. The ferroptosis mediation patterns of individual samples were quantified by ferropscore using the principal component analysis algorithm. The typical ferroptosis-related genes with prognostic roles were further randomly validated using immunohistochemical staining, real-time polymerase chain reaction and western blotting. Results: Three different ferroptosis mediation patterns were identified. The abundance of infiltration of 23 immune cells was different among the three mediation patterns. The quantification of ferroptosis mediation patterns in individual samples served as a promising tool for predicting patient survival outcomes; immune cell infiltration abundance; tumour mutation burden; oncogenic mutation status and tumour grade, stage and molecular subtypes. Low ferropscore combined with high tumour mutation burden was associated with the best survival prognosis. Expressions of PD-L1 (p < 0.001), PD-1 (p = 0.002) and CTLA-4 (p = 0.003) were all significantly upregulated in the high ferropscore group. Low ferropscores also predicted good immunotherapy response for anti-CTLA4 strategy. The mRNA and protein levels of FADS2, a typical ferroptosis-related gene used in the study, were higher in bladder cancer cell lines than in controlled SV-HUC-1 cells. In addition, immunohistochemical staining revealed significantly higher expression levels of FADS2 in human bladder cancer tumour tissues than in normal tissues. Conclusion: This study identified three distinct ferroptosis mediation patterns in bladder cancer. Quantification of ferroptosis mediation patterns in individual samples may help to improve the understanding of multiomic characteristics and guide future immunotherapy responses to bladder cancer. Frontiers Media S.A. 2022-01-25 /pmc/articles/PMC8821925/ /pubmed/35145965 http://dx.doi.org/10.3389/fcell.2022.791630 Text en Copyright © 2022 Liu, Zhang, Zhang, Meng, Wang, Lv, Xia, Wu, Zhang and Wang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cell and Developmental Biology
Liu, Jingchao
Zhang, Zhipeng
Zhang, Wei
Meng, Lingfeng
Wang, Jiawen
Lv, Zhengtong
Xia, Haoran
Wu, Meng
Zhang, Yaoguang
Wang, Jianye
Ferroptosis Mediation Patterns Reveal Novel Tool to Implicate Immunotherapy and Multi-Omics Characteristics in Bladder Cancer
title Ferroptosis Mediation Patterns Reveal Novel Tool to Implicate Immunotherapy and Multi-Omics Characteristics in Bladder Cancer
title_full Ferroptosis Mediation Patterns Reveal Novel Tool to Implicate Immunotherapy and Multi-Omics Characteristics in Bladder Cancer
title_fullStr Ferroptosis Mediation Patterns Reveal Novel Tool to Implicate Immunotherapy and Multi-Omics Characteristics in Bladder Cancer
title_full_unstemmed Ferroptosis Mediation Patterns Reveal Novel Tool to Implicate Immunotherapy and Multi-Omics Characteristics in Bladder Cancer
title_short Ferroptosis Mediation Patterns Reveal Novel Tool to Implicate Immunotherapy and Multi-Omics Characteristics in Bladder Cancer
title_sort ferroptosis mediation patterns reveal novel tool to implicate immunotherapy and multi-omics characteristics in bladder cancer
topic Cell and Developmental Biology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8821925/
https://www.ncbi.nlm.nih.gov/pubmed/35145965
http://dx.doi.org/10.3389/fcell.2022.791630
work_keys_str_mv AT liujingchao ferroptosismediationpatternsrevealnoveltooltoimplicateimmunotherapyandmultiomicscharacteristicsinbladdercancer
AT zhangzhipeng ferroptosismediationpatternsrevealnoveltooltoimplicateimmunotherapyandmultiomicscharacteristicsinbladdercancer
AT zhangwei ferroptosismediationpatternsrevealnoveltooltoimplicateimmunotherapyandmultiomicscharacteristicsinbladdercancer
AT menglingfeng ferroptosismediationpatternsrevealnoveltooltoimplicateimmunotherapyandmultiomicscharacteristicsinbladdercancer
AT wangjiawen ferroptosismediationpatternsrevealnoveltooltoimplicateimmunotherapyandmultiomicscharacteristicsinbladdercancer
AT lvzhengtong ferroptosismediationpatternsrevealnoveltooltoimplicateimmunotherapyandmultiomicscharacteristicsinbladdercancer
AT xiahaoran ferroptosismediationpatternsrevealnoveltooltoimplicateimmunotherapyandmultiomicscharacteristicsinbladdercancer
AT wumeng ferroptosismediationpatternsrevealnoveltooltoimplicateimmunotherapyandmultiomicscharacteristicsinbladdercancer
AT zhangyaoguang ferroptosismediationpatternsrevealnoveltooltoimplicateimmunotherapyandmultiomicscharacteristicsinbladdercancer
AT wangjianye ferroptosismediationpatternsrevealnoveltooltoimplicateimmunotherapyandmultiomicscharacteristicsinbladdercancer